Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04383808 · ClinicalTrials.gov registry record · NA

Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR

A NA study of Brain Disease, sponsored by Stanford University.

Recruiting
Registry status
NA
Development phase
40
Enrollment target
1
Study location

NCT04383808 is a NA study of Brain Disease that is actively recruiting participants, run by Stanford University. The registered enrollment target is 40 participants, below the 737-participant average among 8 other Brain Disease trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04383808, a NA study of Brain Disease, is actively recruiting participants, sponsored by Stanford University.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target
1
Study location

Study Summary

The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a commercial whole-body permanently integrated PET/MRI system using a common radiopharmaceutical.

Conditions Studied

Interventions

  • DIAGNOSTIC_TEST Injected radiotracer with PET Insert
  • DIAGNOSTIC_TEST Pre-injected group with PET insert

Study Locations (1)

California

  • Stanford University - Palo Alto

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-04-01
Est. Completion 2028-03-31
Phase NA

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT04383808

The ClinicalTrials.gov registry entry for NCT04383808 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 737-participant average among 8 other Brain Disease trials with a reported enrollment target (95% lower). The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Brain Disease appearing as the primary indexed condition, and to 2 interventions - of which Injected radiotracer with PET Insert is the first listed.

NCT04383808 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04383808 about?

NCT04383808 is a clinical study titled "Clinical Translation of a Novel Brain PET Insert for Simultaneous PET/MR". The primary goal of this project is to study the feasibility of a brain-dedicated PET insert for an MR scanner for simultaneous acquisition of PET/MR images of human brains. The study will also allow us to compare the imaging performance of the investigator's brain-dedicated PET insert against a com...

What is the current status of trial NCT04383808?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-04-01. Estimated completion is 2028-03-31.

What conditions does trial NCT04383808 study?

This clinical trial studies the following conditions: Brain Disease.

What interventions are being tested in trial NCT04383808?

The interventions under investigation include: Injected radiotracer with PET Insert (DIAGNOSTIC_TEST), Pre-injected group with PET insert (DIAGNOSTIC_TEST).

Who is sponsoring clinical trial NCT04383808?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04383808 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Brain Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.